Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Unique microRNAs appear at different times during the course of a delayed-type hypersensitivity reaction in human skin

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Repeated treatments with ingenol mebutate for prophylaxis of UV-induced squamous cell carcinoma in hairless mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Ablative fractional laser alters biodistribution of ingenol mebutate in the skin

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Allergic contact dermatitis to nickel is characterized by a specific micro-RNA signature

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8(+) IL-17(+) T Cells in Psoriasis Lesions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Diphencyprone (DPCP) is a hapten that induces delayed-type hypersensitivity (DTH) reactions. MicroRNAs (miRNAs) are short non-coding RNAs that negatively regulate gene expression and have been implicated in various inflammatory skin diseases, but their role in DTH reactions is not well understood. We generated global miRNA expression profiles (using next-generation sequencing) of DPCP reactions in skin of seven healthy volunteers at 3, 14 and 120 days after challenge. Compared to placebo-treated sites, DPCP-challenged skin at 3 days (peak inflammation) had 127 miRNAs significantly deregulated. At 14 days (during resolution of inflammation), 43 miRNAs were deregulated and, at 120 days (when inflammation had completely resolved), six miRNAs were upregulated. While some miRNAs have been observed in psoriasis or atopic dermatitis, most of the deregulated miRNAs have not yet been studied in the context of skin biology or immunology. Across the three time points studied, many but not all miRNAs were uniquely expressed. As various miRNAs may influence T cell activation, this may indicate that the miRNAs exclusively expressed at different time points function to promote or resolve skin inflammation, and therefore, may inform on the paradoxical ability of DPCP to treat both autoimmune conditions (alopecia areata) and conditions of ineffective immunity (melanoma).

OriginalsprogEngelsk
TidsskriftExperimental Dermatology
Vol/bind24
Udgave nummer12
Sider (fra-til)953-7
Antal sider5
ISSN0906-6705
DOI
StatusUdgivet - dec. 2015

ID: 46308428